“User Experience” has become a ubiquitous buzzword. Walk into any product meeting or browse a venture deck, and you’ll hear UX framed almost exclusively around industrial design, haptic feedback, or the unboxing ritual of premium packaging.
While the cannabis industry has made serious progress here, we’re still hitting a ceiling. Cannabis companies are optimizing for the moment of consumption while ignoring the reality of the consumer.
RELATED: Cannabis users are chasing relief, not a high
The Narrow Definition of UX
In traditional tech development, UX encompasses the entire user journey, from discovery and adoption to long-term retention. In cannabis, it is often reduced to aesthetics: how a device feels in the hand or how smoothly it delivers vapor.
That’s incomplete. For a large portion of consumers, especially medical patients and underserved populations, the hardest part of the journey isn’t the act of inhalation. It’s the friction that exists before and after that moment.
Real-world friction looks like this:
- Dosing Confusion: “How much is enough, and what should I actually expect?”
- Information Asymmetry: Education that is either buried in marketing jargon or inconsistent across platforms.
- Post-Purchase Abandonment: A total lack of guidance once the transaction is complete.
- Environmental Constraints: The looming question of where a person can actually use this without social or legal consequences.
None of these are edge cases. They are core product problems that we, as leaders, are failing to treat as such.
A Case Study in Friction: The Veteran Journey
Veterans highlight this UX gap more clearly than any other demographic. This is a population with high clinical need (chronic pain, PTSD), high intent (actively seeking alternatives to opioids), and disproportionately high friction.
Data shows that four out of ten Veterans with chronic pain already use medical cannabis as part of their care strategy. Yet their user journey is a series of systemic breakdowns. They navigate federal ambiguity, VA-related benefit concerns, and housing restrictions.
RELATED: Most cannabis brands aren’t built to scale – here’s why
From a product perspective, when a disabled Veteran has to travel down the street in a wheelchair just to find a ‘safe’ spot to consume, the UX has failed. Not because the device didn’t work, but because the system around it was never designed for their reality.
When the experience of using cannabis is too risky or socially costly, patients often revert to opioid-based treatments. Cannabis offers a different trajectory, but only if product leadership accounts for the environment of the user.
Redefining Innovation as Enablement
If the industry wants to mature, we must expand our definition of UX to include environmental compatibility. In shared or government-subsidized housing, the odor of cannabis is a liability. It triggers lease violations and social stigma. Hardware that doesn’t account for the olfactory footprint of the medicine effectively bars those in multi-family housing from participating in the market.
Real UX in cannabis should be measured by:
- Affordability: Is the cost-of-use sustainable for a fixed-income patient?
- Guidance: Is there a feedback loop that supports the user after the sale?
- Trust: Does the process feel as safe as the product?
- Discretion: Can the user find relief without impacting their neighbors or risking their housing?
From Design to Enablement
The most important shift we can make is moving from designing products to enabling users. This means designing for constrained, real-world environments, not the ideal use cases featured in lifestyle photography.
RELATED: This one thing can make or break a cannabis business
If cannabis is to meaningfully replace traditional pharmaceuticals, our UX standard must be higher. The defining question for the next generation of product leaders is whether a person can use their medicine consistently and safely without jeopardizing the rest of their life.
*This article was submitted by an unpaid guest contributor. The opinions or statements within do not necessarily reflect those of GreenState or HNP. The author is solely responsible for the content.